by Jessica Casebolt | Mar 29, 2023 | Public Health/Prevention, Tea Leaves
The Biden administration warned Congress on Monday that the nation’s efforts to develop and stockpile key medicines for guarding against public health threats are underfunded by some $35 billion. Over the next five years, the Department of Health and Human...
by Jessica Casebolt | Mar 29, 2023 | Providers, Tea Leaves
A new report from Kaufman Hall says that although hospital margins remain flat, they are stable. The report found that the unpredictability that plagued hospital margins for the last three years is relaxing as small margins become the new normal. External economic...
by Jessica Casebolt | Mar 29, 2023 | Payers, Tea Leaves
UnitedHealthcare, the nation’s largest health insurer, is expected to announce plans today to reduce the number of prior authorization requirements for a list of medical procedures and devices. The insurer also said it would eliminate, starting next year, many...
by Jessica Casebolt | Mar 29, 2023 | Life Sciences, Tea Leaves
The Food and Drug Administration scheduled a May advisory meeting to discuss if HRA Pharma’s birth control pill should be available over the counter, an approval that would be the first of its kind from the agency. FDA advisers originally planned to review the...
by Jessica Casebolt | Mar 28, 2023 | Tea Leaves, Transition to Value
Wellvana Health, a value-based care technology company that assumes downside risk for partner physicians through an underwriting program, has reached $84 million in a series B round of funding. The investment was co-led by Heritage Group and Valtruis with...
by Jessica Casebolt | Mar 28, 2023 | Opioid/Substance Use Disorders, Tea Leaves
A Pennsylvania program that incorporates addiction treatment into emergency care for opioid use disorder could help limit the high risk of death for patients who overdose after they’re discharged, according to a study published in JAMA Health Forum. Emergency...
Recent Comments